204 related articles for article (PubMed ID: 22537429)
1. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation.
Murphy N; Cowley TR; Blau CW; Dempsey CN; Noonan J; Gowran A; Tanveer R; Olango WM; Finn DP; Campbell VA; Lynch MA
J Neuroinflammation; 2012 Apr; 9():79. PubMed ID: 22537429
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization.
Grieco M; De Caris MG; Maggi E; Armeli F; Coccurello R; Bisogno T; D'Erme M; Maccarrone M; Mancini P; Businaro R
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299330
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
[TBL] [Abstract][Full Text] [Related]
5. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
6. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.
Basavarajappa BS; Nagre NN; Xie S; Subbanna S
Hippocampus; 2014 Jul; 24(7):808-18. PubMed ID: 24648181
[TBL] [Abstract][Full Text] [Related]
7. The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity.
Colangeli R; Pierucci M; Benigno A; Campiani G; Butini S; Di Giovanni G
Sci Rep; 2017 Sep; 7(1):11152. PubMed ID: 28894217
[TBL] [Abstract][Full Text] [Related]
8. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.
Segev A; Korem N; Mizrachi Zer-Aviv T; Abush H; Lange R; Sauber G; Hillard CJ; Akirav I
Neuropsychopharmacology; 2018 Sep; 43(10):2017-2027. PubMed ID: 29977073
[TBL] [Abstract][Full Text] [Related]
9. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Su SH; Wu YF; Lin Q; Hai J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
12. The age-related attenuation in long-term potentiation is associated with microglial activation.
Griffin R; Nally R; Nolan Y; McCartney Y; Linden J; Lynch MA
J Neurochem; 2006 Nov; 99(4):1263-72. PubMed ID: 16981890
[TBL] [Abstract][Full Text] [Related]
13. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
14. The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats.
Ferizovic H; Spasojevic N; Stefanovic B; Jankovic M; Dronjak S
Int Immunopharmacol; 2020 Aug; 85():106615. PubMed ID: 32447219
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
Zer-Aviv TM; Akirav I
Hippocampus; 2016 Jul; 26(7):947-57. PubMed ID: 26928784
[TBL] [Abstract][Full Text] [Related]
16. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
17. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
Bambico FR; Duranti A; Nobrega JN; Gobbi G
Eur Neuropsychopharmacol; 2016 Mar; 26(3):578-90. PubMed ID: 26747370
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP).
Eriksen GS; Jacobsen LM; Mahmood A; Pedersen LM; Gjerstad J
Brain Res Bull; 2012 Feb; 87(2-3):234-7. PubMed ID: 22133920
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators.
Tham CS; Whitaker J; Luo L; Webb M
FEBS Lett; 2007 Jun; 581(16):2899-904. PubMed ID: 17543306
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Skrzydlewska E
Adv Med Sci; 2019 Mar; 64(1):15-23. PubMed ID: 30243113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
